Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Kaufman JL, Mina R, Shah JJ, Laubach JP, Nooka AK, Lewis C, Gleason C, Sharp C, Harvey RD, Heffner LT, Richardson P, Lonial S, Orlowski RZ. Kaufman JL, et al. Among authors: richardson p. Clin Lymphoma Myeloma Leuk. 2020 Dec;20(12):797-803. doi: 10.1016/j.clml.2020.07.013. Epub 2020 Jul 25. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32819881 Free article. Clinical Trial.
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC. Gupta D, et al. Among authors: richardson p. Leukemia. 2001 Dec;15(12):1950-61. doi: 10.1038/sj.leu.2402295. Leukemia. 2001. PMID: 11753617
NF-kappa B as a therapeutic target in multiple myeloma.
Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC. Hideshima T, et al. Among authors: richardson p. J Biol Chem. 2002 May 10;277(19):16639-47. doi: 10.1074/jbc.M200360200. Epub 2002 Feb 28. J Biol Chem. 2002. PMID: 11872748 Free article.
Thalidomide in multiple myeloma.
Richardson P, Hideshima T, Anderson K. Richardson P, et al. Biomed Pharmacother. 2002 May;56(3):115-28. doi: 10.1016/s0753-3322(02)00168-3. Biomed Pharmacother. 2002. PMID: 12046682 Review.
Novel therapeutic approaches for multiple myeloma.
Hideshima T, Richardson P, Anderson KC. Hideshima T, et al. Among authors: richardson p. Immunol Rev. 2003 Aug;194:164-76. doi: 10.1034/j.1600-065x.2003.00053.x. Immunol Rev. 2003. PMID: 12846814 Review.
Proteasome inhibitor therapy in multiple myeloma.
Chauhan D, Hideshima T, Mitsiades C, Richardson P, Anderson KC. Chauhan D, et al. Among authors: richardson p. Mol Cancer Ther. 2005 Apr;4(4):686-92. doi: 10.1158/1535-7163.MCT-04-0338. Mol Cancer Ther. 2005. PMID: 15827343 Review.
2,365 results